RxDoctor Payments Data

Peter Walts, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Carmel, INNPI 1417982620

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 74.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $6,467, 3.2 times the $2,005 reported in 2019.

$17,848in general payments, 2019–2025

Across 116 payments — averaging $153.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$13K
  • Abbott$2K
  • Medtronic$2K
  • Abiomed$346
  • Atricure, Inc.$238
  • Helios Cardio Inc$194
  • plus $47 from 2 others
$113,901in research payments, 2019–2025

Across 9 payments — averaging $12,656 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$84K
  • Atricure, Inc.$30K

What the payments were for

  • Consulting fees$6,05034%
  • Travel & lodging$7,00339%
  • Food & beverage$4,79527%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences76$13,202
Abbott16$1,943
Medtronic(2 entities)16$1,880
Abiomed3$346
Atricure, Inc.2$238
Helios Cardio Inc1$194
Chiesi USA, Inc.1$29
Smith+Nephew1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,848 in reported general payments places this provider in the 80th percentile of 127 thoracic surgery (cardiothoracic vascular surgery) providers in Indiana.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Indiana

Medicare billing

Part B allowed, 2024
$299,266
Medicare patients
213
Services billed
527

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate36$322
Atorvastatin Calcium11$115
Metoprolol Tartrate27$63
Potassium Chloride16$51
Amoxicillin27$28
Furosemide19$14

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →